ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
ReShape Lifesciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 1.47M | -1.76M | -1.58M | -1.59M | -2.19M | -1.7M | -3.53M | -3.49M | -2.66M | -16.61M | -12.19M | -9.44M | -8.21M | -35.46M | -17.7M | -3.9M | -4.87M |
Depreciation & Amortization | 4K | 5K | 5K | 6K | 6K | 7K | 50K | 49K | 48K | 515K | 543K | 545K | 550K | 555K | 548K | 450K | 418K |
Stock-Based Compensation | 15K | 15K | 32K | 65K | 72K | 110K | 216K | 218K | 222K | 130K | 358K | 770K | 719K | 2.29M | 10.72M | -364K | 101K |
Other Working Capital | -93K | 114K | -1.74M | 187K | -47K | 157K | 164K | -138K | -520K | -523K | 79K | 79K | -83K | 80K | -3.9M | 1.12M | -264K |
Other Non-Cash Items | -3.76M | 375K | 1.95M | -91K | -829K | -142K | 704K | -332K | -2.62M | 12.4M | -3K | 2K | 84K | 17K | 23K | 66K | 521K |
Deferred Income Tax | -4K | 6K | -1K | n/a | 1K | 27K | 2K | 4K | -1K | 132K | -368K | -1K | -187K | 28.85M | 2.97M | 142K | 1.99M |
Change in Working Capital | 156K | 673K | -712K | 258K | 454K | -761K | -218K | -3.11M | -47K | 604K | -1.1M | 1.4M | -357K | 314K | -4.36M | 1.42M | -115K |
Operating Cash Flow | -2.12M | -687K | -311K | -1.36M | -2.07M | -2.46M | -2.78M | -6.66M | -5.06M | -2.83M | -5.27M | -6.42M | -7.38M | -3.43M | -7.8M | -2.19M | -1.96M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36K | -7K | -79K | -33K | -12K | -7K | -67K | -89K | -77K | -119K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -33K | n/a | 33K | n/a | n/a | n/a | 30K | 9K | -3M | -5.21M | 5.21M | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 3.24M | n/a | n/a | 10.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33K | -10.2M | -39K | n/a | 30K | 9K | -5.21M | 5.21M | 5.21M | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | 3.2M | n/a | -3K | -7K | -79K | -33K | 18K | 2K | -3.07M | -89K | 5.13M | -119K |
Debt Repayment | -811K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.76M | 653K | n/a | 24K | n/a | 5.46M | -338K | 2.25M | n/a | 638K | 3K | 2.49M | n/a | n/a | -3.23M | 35.33M | n/a |
Financial Cash Flow | 3.95M | 653K | n/a | 24K | n/a | 5.46M | -338K | 2.25M | 10.2M | 638K | 3K | 2.49M | n/a | n/a | -3.03M | 35.33M | 1M |
Net Cash Flow | 1.82M | -50K | -310K | -1.33M | -2.08M | 3.01M | -3.12M | -4.42M | 5.13M | -2.29M | -5.3M | -3.92M | -7.36M | -6.48M | -10.92M | 38.27M | -1.06M |
Free Cash Flow | -2.12M | -687K | -311K | -1.36M | -2.07M | -2.46M | -2.78M | -6.7M | -5.07M | -2.91M | -5.31M | -6.43M | -7.38M | -3.49M | -7.89M | -2.27M | -2.08M |